Introduction
Staphylococcus aureus, a notorious pathogen, can secrete several exotoxins, such as α-hemolysin, enterotoxins, coagulase, and protein A, all of which may be capable of causing a series of acute and chronic infections, such as infective endocarditis and osteomyelitis, and is a frequent invader in chronic lung disease [1, 2] . Furthermore, it has been reported to be a serious threat owing to the appearance of multidrug-resistant strains, such as methicillinresistant S. aureus and vancomycin-methicillin-resistant S. aureus [3] . S. aureus attaches preferentially to a variety of surfaces, and then forms a community encased by an extracellular matrix of protein, polysaccharide, and nucleic acids, called a biofilm, which protects S. aureus from antibiotics and the host immune system [4] . Therefore, biofilms have shown to house 100-1,000-fold increases in tolerance towards antimicrobial agents compared with equivalent populations of their free-floating counterparts [5] . Once biofilms colonize the indwelling medical devices, it becomes almost impossible to clear the infections [6] . Thus, there is an urgent need to find an effective combination therapy or novel drugs to overcome the problem caused by biofilm-associated S. aureus.
To try to find feasible sources of anti-biofilm agents, many investigators have begun to extract and analyze the metabolites from a number of plants and marine organisms [7, 8] . For example, quercetin and tannic acid extracted from Alnus japonica have been reported to inhibit the formation of recalcitrant biofilm of S. aureus without disrupting cell growth [9] . An extracellular protease in actinomycete culture supernatants inhibits and detaches S. aureus biofilm formation in a non-microbicidal manner [10] . Additionally, two classes of marine sponge metabolites are demonstrated to be non-bactericidal biofilm modulators; namely, the terpenoids and the pyrrole-imidazoles, such as (-)-ageloxime-D towards S. epidermidis, and trans-bromoageliferin and cis-bromoageliferin towards Pseudomonas aeruginosa [11] [12] [13] [14] [15] [16] .
The diverse mechanisms and environmental conditions that contribute to biofilm formation and disassembly of S. aureus include intercellular adhesion proteins, quorum sensing, protease, DNase, cis-2-decenoic acid, D-amino acids, phenol-soluble polypeptides, and pH change [17] . Quercetin and tannic acid repressed the transcription of two intercellular adhesion-related genes (icaA and icaD), the quorum-sensing gene agrA, and two virulenceregulatory genes (sigB and sarA), all of which are important for the formation of biofilms of S. aureus [9] . Magnolol, a major component isolated from the stem bark of Magnolia species, has anti-biofilm properties against S. aureus through reducing S. aureus autolysin activity in a dosedependent manner and then controlling lysis and eDNA release that are essential for S. aureus biofilm formation [18] [19] [20] . The 2-aminoimidazole motif found in the spongederived natural products might be functioning as a biofilm inhibitor through a zinc chelation mechanism [21] .
Many secondary metabolites, including chromones like quercetin [9] , alkaloids such as pyrrole-imidazole alkaloids, trans-bromoageliferin and cis-bromoageliferin from marine sponges [6] , anthraquinones such as alzarin, purpurin, emodin, and quinalizarin [3] have been reported to inhibit the biofilm formation of Pseudomonas and/or Staphylococcus species. Meanwhile, cyclic peptides such as rhamnolipid and sufactin could reduce the adhesion and remove biofilms of individual and mixed cultures of food pathogenic bacteria, including S. aureus [22] . Two hydroxyl units at the C-1 and C-2 positions of anthraquinones were verified to be important for antibiofilm and anti-hemolytic activities in S. aureus [3] . Marine fungi have been considered as hotshots in recent research owing to their wide distribution and their various secondary metabolites, including chromones, alkaloids, anthraquinones, etc., with wide ranges of bioactivities and remarkable safety records. In this context, the aim of this study was to screen the inhibiting activities of 106 natural products, including 9 simple phenol derivatives, 19 citrinin derivatives, 28 chromones, 6 anthraquinones, 25 alkaloids, 11 esters, 4 cyclic peptides, 3 pyrroles, and 1 polyol, isolated from marine-derived fungi against the biofilm formation of S. aureus and to analyze the structural motif important for the anti-biofilm activity. Additionally, the underlying mechanisms of secalonic acid D (the most bioactive compound) in inhibiting biofilm formation were investigated through confocal microscopy, cell aggregation assay, transcriptional analysis, and synergistic effects with other important antibiotics to S. aureus (penicillin, vancomycin, and chloramphenicol). The results showed that natural products, such as SAD, from marine-derived fungi might possess potential as a non-microbicidal strategy against S. aureus.
Materials and Methods

Bacterial Strains and Tested Compounds
S. aureus ATCC 6538 was obtained from the American Type Culture Collection (ATCC) and routinely cultivated at 37°C in Luria Bertani (LB) medium [3] . All of the tested compounds, including phenol derivatives, citrinin derivatives, chromones, anthraquinones, alkaloids, cyclic peptides, pyrroles, ethers, and polyols (see Fig. S1 ), were isolated from the fermentation broth of marine-derived fungi (see Table 1 and Fig. S1 ) in our laboratory, such as Penicillium sp. SCSGAF 0023 (CCTCC M 2012507) [23, 24] , Aspergillus sp. SCSGAF 0076 (CCTCC M 2012397) [25, 26] , Engyodontium album DFFSCS021 (CCTCC M 2014521) [27] , and Aspergillus westerdijkiae DFFSCS013 (CCTCC M 2013078) [28] , which were deposited in the China Center for Type Culture Collection (CCTCC). The fungal fermentation broth, after 30-day static incubation of each marine fungus, was collected and filtered through cheesecloth to separate the supernatant and mycelia. The supernatant was mixed with XAD-16 resin, and mycelia were extracted with 80% acetone. The resin and acetone extracts were evaporated and extracted with ethyl acetate to afford the brown crude gum. The crude gum was subjected to repeated column chromatography, including HLPC with an ODS column, semipreparative HLPC, and reversed-phase-medium pressure preparative liquid chromatography, to give tested compounds with >90% purity. All of the tested compounds were dissolved in dimethyl sulfoxide (DMSO; Sigma, USA) and kept at -20°C.
Biofilm Formation and Destruction Assay
S. aureus biofilm formation in static condition was detected in pre-sterilized polystyrene flat-bottomed 96-well plates (Corning, USA) [10, 29] . Briefly, S. aureus cells cultivated overnight were diluted to an optical density (OD ) of about 0.01 with fresh LB medium, and then 150 µl dilutions were incubated with different concentrations of each compound in 96-well plates without shaking at 37°C. Cells in LB medium with DMSO were used as the control, and LB medium with DMSO was used as the blank control. After 24 h, the contents were discarded, and the plates were washed, dried, and stained with 170 µl of 0.1% crystal violet (Shanghai Chemical Reagents Co. Ltd, China) for 30 min. Subsequently, 200 µl of 30% acetic acid was added to each well after the plates were washed and dried at room temperature. The absorbance at 570 nm was determined using a Multiskan GO Reader (Thermo Scientific, USA). Biofilm inhibition was calculated using the following formula: Percentage biofilm inhibition = [(Control OD "-" shows the inhibitory rates from -20% to 20%, which means no obvious differences between the treatments with and without compounds.
value was defined as -20% to 20%. To study the dynamic changes of S. aureus biofilm formation caused by potential compounds, the biofilm formation of S. aureus with different concentrations of drugs (1.56, 3.12, 6.25, and 12.5 µg/ml) and at different intervals (6, 12 , and 24 h) was detected. To further study the effects of potential compounds on already developed biofilms, the biofilms grown in 96-well plates for 24 h as described above were treated with different concentrations of the compounds (3.12, 6.25, and 12.5 µg/ml) for 24 h. After incubation, the plates were stained with crystal violet.
Cell Growth Curve
S. aureus cells grown overnight were diluted with fresh LB medium to an OD was monitored and recorded in an automatic spectrophotometer (Bioscreen, Finland) at every 3 h. All experiments were performed in eight replicates.
Confocal Laser Scanning Microscopy (CLSM)
Pre-sterilized glass microscope slides were used to observe biofilms by CLSM as described in the previous study [29, 30] . Briefly, cells were grown in LB medium overnight and diluted with fresh LB medium to an OD 6 0 0 of about 0.01. Then, 2 ml dilutions were incubated with or without different concentrations of compounds (1.5, 3, and 6 µg/ml) in 12-well plates with a glass microscope slide in each well under static conditions. After 24 h, the glass slides were gently moved out and rinsed with deionized water to remove loosely attached cells. The biofilms on one side were stained with 5 µM SYTO9 dye (Sigma) in the dark, and those on the other side were wiped off. After 15 min, the slides were washed, and observed by CLSM (LSM 710 Zeiss, Germany) with a 60× objective lens to visualize the biofilms. The 488 nm excitation and 520 nm emission filter settings were used for detection of SYTO 9. Furthermore, quantification of biofilm parameters was processed with the COMSAT software using the CLSM images [31] .
Cell Aggregation
Cell aggregation was assayed as reported previously [32] . Briefly, cells were grown in LB medium overnight and diluted with fresh LB medium to an OD RNA Isolation and qRT-PCR S. aureus was grown in LB medium overnight and diluted to an OD 6 0 0 of about 0.01 and then was incubated with or without potential compounds in 12-well plates for 24 h under static conditions. Planktonic bacteria and formed biofilms in each well were harvested, and the total RNAs were extracted using RNAiso Plus Reagent (Takara, China) and transcribed reversely into cDNA with PrimeScript RT reagent kit (Takara) according to the manufacturer's directions. Ten-fold dilutions of each cDNA were used as templates to assess the transcriptional levels of 17 genes via qRT-PCR with paired primers and 16S rRNA as an internal standard, using SYBR Premix Ex Taq (Takara) ( Table S1) . The relative transcription level of each gene was defined as the ratio of its transcript of biofilms grown in the indicated concentration of compounds over that in LB medium with DMSO, using the 2
method [33] . The threshold cutoff was set to 1.5 (relative transcriptional levels > 1.5 or < 0.66), which means that it would be regarded to influence biofilm formation to a degree, when (compared with those in control cells) transcripts in cells treated with SAD either increased by >50% or decreased by >0.34%.
Combination Testing of SAD with Three Antibiotics on S. aureus Growth and Biofilm Formation Penicillin and chloramphenicol are known to be important bactericides to S. aureus, and vancomycin is a preferred antibiotic to treat the infection caused by gram-positive bacteria in clinics. Therefore, in order to observe the synergistic effects of SAD, three kinds of antibiotics (ampicillin sodium salt, chloramphenicol, and vancomycin HCl) at their sub-MIC concentrations were chosen to combine with 1 µg/ml SAD, which could inhibit the biofilm formation of S. aureus by <20%. The minimum inhibitory concentrations (MIC) of the three antibiotics were assayed in 96-well plates. Wells containing 100 µl S. aureus dilutions (OD 6 0 0 = 0.01) were supplemented with different concentrations of ampicillin sodium salt (0 to 0.2 µg/ml), vancomycin HCl (0 to 2 µg/ml), and chloramphenicol (0 to 26 µg/ml) separately, and incubated at 37°C for 24 h. After incubation, the OD = 0.01) with 1 µg/ml SAD and different sub-MIC concentrations of ampicillin sodium salt (MIC: 0.05 µg/ml), vancomycin HCl (MIC: 1.2 µg/ml), or chloramphenicol (MIC: 6.5 µg/ml) were added into 96-well microtiter plates. For cell growth, the microtiter plates were incubated for 24 h at 37°C with shaking. Biofilm formation was initiated in the microtiter plates and incubated at 37°C for 24 h as described above. The absorbance at 570 nm or 600 nm was determined using a Multiskan GO Reader (Thermo Scientific). All experiments were performed in six replicates.
Data Analysis
Results from eight replicates were expressed as the mean ± standard deviation (SD) and statistical analysis was subjected to one-factor analysis of variance performed with the Data Processing System software [34] . Significant differences were considered at a p value of <0.05 in all experiments.
Results
Anti-Biofilm Effects of 106 Compounds
To find new anti-biofilm drugs, 106 compounds ( Fig. S1 ) isolated from marine-derived fungi were tested in 96-well plates against the biofilm formation of S. aureus. The results showed that 18 compounds (Fig. 1) had certain effects on S. aureus growth and biofilm formation at the concentration of 100 μg/ml, where the inhibitory percentage is over the cutoff value, and especially 12 compounds exhibited notable anti-biofilm activity with an inhibiting rate of >50% (Table 1) , whereas the other 88 compounds had no obvious activity compared with the negative treatment, with inhibitory rates from -20% to 20%. To further verify the anti-biofilm activity of the 12 bioactive compounds, lower concentrations of these compounds were diluted and added into the culture of S. aureus. Four compounds (emodin, citrinin, and secalonic acids B and D) still showed strong anti-biofilm activity at the concentration of 12.5 μg/ml (Table 1) . Specifically, secalonic acids B and D inhibited S. aureus biofilm formation by >90% without reducing cell growth at lower concentrations (Table 1) , whereas biofilm formation by Pseudomonas aeruginosa PAO1 was not affected by secalonic acids B and D at concentrations up to 100 μg/ml, where the inhibitory rate was about 10%.
The 106 tested compounds (Fig. S1 ) included 9 simple phenol derivatives, 19 citrinin derivatives, 28 chromones, 6 anthraquinones, 25 alkaloids, 11 esters, 4 cyclic peptides, 3 pyrroles, and 1 polyol. Comparison of the structurebioactivity of these citrinin derivatives, chromones, and anthraquinones, respectively, indicated that the double bond between C-1 and C-10 of the skeleton might be important for the anti-biofilm activity of citrinin derivatives, and the substituents on the benzene rings of chromone and anthraquinone skeletons can significantly affect their antibiofilm activities. Furthermore, comparison of the structure-bioactivity of penicillixanthone A, and secalonic acids B and D suggested that the C-C connection position of two chromone monomers will significantly affect their anti-biofilm activities.
Secalonic Acid D Inhibited Biofilm Formation and Accelerated Biofilm Detachment
The effects of secalonic acid D (SAD) on S. aureus biofilm formation were further evaluated in more detail in 96-well plates. SAD inhibited S. aureus biofilm formation in a dosedependent manner, and the inhibitory rate of biofilm formation was almost up to 97% at the concentration of 6.25 μg/ml (Fig. 2A) . Secalonic acid B, an epimer of secalonic acid D, also inhibited biofilm formation dosedependently with the similar inhibition rate (Fig. 2B) . Furthermore, the curves of biofilm development in response to different concentrations of SAD were also assayed. The results showed that SAD mainly decreased the rate of biofilm development during 12-24 h, which suggested that SAD may inhibit the formation and maturation of S. aureus biofilm (Fig. 2C) . Additionally, after the S. aureus developed biofilms were treated with different concentrations of SAD, the OD
of LB medium supplemented with 3.12-12.5 μg/ml SAD decreased by 34.2-43.7% compared with the OD (Fig. 2D) . These results showed that SAD inhibited biofilm development dose/time-dependently and slightly accelerated biofilm eradication in S. aureus.
S. aureus biofilms
SAD Influenced the Biofilm Architecture
CLSM studies were applied to analyze the effect of SAD on the S. aureus architecture, using glass slides after cells were stained with SYTO9. The CSLM images showed a typical biofilm on the surface of the glass slides in LB medium, whereas a sparse biofilm existed on the glass slides in LB medium supplemented with SAD, which varied in response to different concentrations (Figs. 3A and  S2 ). COMSTAT analysis of the CSLM images showed that the total biomass and average thickness of the S. aureus biofilms were decreased dose-dependently by 30.9-53.8% and 24.9-44.8%, respectively, but the roughness coefficient and surface-to-biovolume ratio increased dose-dependently by 3,600-6,900% and 19.8-67.8%, respectively, in response to SAD (Figs. 3B-3E ). However, there was no significant difference in maximum thickness of S. aureus biofilms when S. aureus was co-incubated with SAD (Fig. 3C) . These results demonstrated that SAD dose-dependently influenced 
Effect of SAD on Cell Growth and Cell Aggregation
To monitor the growth of S. aureus at different intervals, cells treated with SAD at concentrations ranging from 1.56 to 12.5 μg/ml were incubated in Bioscreen C microtiter plates (Labsystems). In the first 6 h, the growth of cells with SAD was severely delayed, but as the incubation time increased, the gap closed and the growth was similar to those without any SAD after 18 h (Fig. 4A) . Moreover, when SAD was added to the media, the percentage aggregation was increased by 53.4%, 89.2%, and 106%, respectively, at the concentrations of 3.12, 6.25, and 12.5 μg/ml, compared with the medium without any SAD (Fig. 4B) . The above results indicated that SAD had ultimately little effect on S. aureus growth but slowed down the rate of growth in the early phase and promoted cell aggregation.
SAD Modulated the Transcriptional Expressions of Biofilm-Related Genes
In order to investigate the underlying molecular mechanism of anti-biofilm activity of SAD in S. aureus, the transcriptional expressions of 17 biofilm-related genes in floating cells and biofilms were detected by real-time qRT-PCR, and the transcriptional confidence threshold cutoff was set to 1.5. In planktonic bacteria, SAD obviously upregulated the transcriptional expression of the quorumsensing gene (agr), biofilm regulator genes (isaA and icaD), protease genes (aur, sspA, and clp), nuclease gene (nuc2), α-hemolysin gene (hla), phenol-soluble modulin genes (PSMα, PSMβ, and hld), and one staphopain protease gene (sspB) by 73.7-2,103%, and down-regulated the transcriptional expression of another staphopain protease gene (scpA) by 60.5% (Fig. 5A) . In formed biofilms, gene hla was also upregulated by 120%, but the expression of agrA, isaA, icaD, aur, clp, nuc2, PSMα, scpA, and another staphopain protease gene (sspC) was repressed by 35.8-86.9% after 3.12 μg/ml SAD was added into the media (Fig. 5B) . In addition, the expression levels of other biofilm regulators (icaA and sigB) were also down-regulated by 44.4-78.4% in response to SAD (Fig. 5B) . These results implicated that SAD inhibited S. aureus biofilm formation through the transcriptional regulation of biofilm regulators, proteases, nucleases, PSMs, and staphopains in planktonic cells and biofilm cells in different ways, which may be another example proving that it is a complex process that governs the formation of S. aureus biofilms.
SAD Synergistically Interacts with Three Antibiotics on S. aureus Growth and Biofilm Formation
Interaction of SAD with three antibiotics (ampicillin sodium salt, vancomycin HCl, or chloramphenicol), which are potent for S. aureus, on S. aureus growth and biofilm formation was tested by the microplate method. Compared with the control and treatments with a single compound, SAD synergistically interacted with the three antibiotics on S. aureus growth and biofilm formation in varying degrees (Figs. 6A-6C ). At 1 μg/ml, SAD reduced the MIC of ampicillin sodium salt (MIC: 0.05 μg/ml) to 0.02 μg/ml, of vancomycin HCl (MIC: 1.2 μg/ml) to 0.8 μg/ml and of chloramphenicol (MIC: 6.5 μg/ml), to 2.5 μg/ml. For ampicillin sodium salt, 1 μg/ml SAD obviously increased its antibacterial activity at both 0.005 and 0.01 μg/ml concentrations by 35.5%, but did not inhibit the increased biofilm formation caused by ampicillin sodium salt. For vancomycin HCl, SAD improved its antibacterial activity and anti-biofilm activity at concentrations of 0.125 and 0.25 μg/ml by about 42.7-48.3%. For chloramphenicol, SAD enhanced its activities at 0.5 μg/ml (but not 0.2 μg/ml) by 14.9% for antibacterial activity and 39.1% for anti-biofilm activity.
Discussion
Marine fungi have been reported to produce various secondary metabolites with various bioactivities. In the present study, the anti-biofilm activities of 106 compounds isolated from marine-derived fungi against S. aureus were detected using the crystal violet staining method in 96-well plates. The results demonstrated that four compounds (emodin, citrinin, and secalonic acids B and D) showed strong anti-biofilm activity with reduction by ≥50% at the concentration of 12.5 μg/ml (Table 1) . Emodin, an anthraquinone, has been reported to reduce the biofilm formation and cell growth of S. aureus MSSA 6538 by ≥70% at 10 μg/ml and Streptococcus mutans by >80% at 5 μg/ml [3, 35] , which was in line with our results. However, there is no report about the anti-biofilm activities of secalonic acids B and D and citrinin against S. aureus in previous studies. SAD could inhibit the pellicle formation of Shewanella onedensis MR-1 at the concentration of 3.125 μg/ml during 12 h of incubation, but the pellicle formation grew as well as those without SAD when the incubation time was increased to 24 h [23] . It was interesting to find that secalonic acids B and D inhibited S. aureus biofilm formation up to 90% without reducing cell growth at the concentration of 6.25 μg/ml, and up to 60% at the concentration of 3.12 μg/ml after 24-h incubation ( Figs. 2A and 2B) , and 1 μg/ml (about 1.57 μM) SAD could synergistically interact with three antibiotics (ampicillin sodium salt, vancomycin HCl, and chloramphenicol) on S. aureus growth and biofilm formation in varying degrees (Figs. 6A-6C) . Furthermore, the results obtained from different incubation hours demonstrated that SAD mainly inhibited biofilm development and slightly detached preformed biofilm, but showed no significant differences at the early phase of S. aureus growth (Figs. 2C and 2D) . Meanwhile, SAD influenced the architecture of S. aureus The line represents the transcriptional levels of genes in the control experiments, which was defined as 100%. Error bar: SD. * p < 0.05.
biofilm by forming sparse biofilm, dose-dependently decreasing the biomass and average thickness, and dosedependently increasing the roughness coefficient and surface-to-biovolume ratio (Fig. 3) . Among the various parameters, the increased surface-to-biovolume ratio and roughness coefficient signified that a high fraction of cells in the S. aureus biofilms were exposed to the bulk liquid, and biofilm heterogeneity increased in response to SAD [31] .
It was reported that two hydroxyl units at the C-1 and C-2 positions of anthraquinones were verified to be important for antibiofilm and anti-hemolytic activities in S. aureus [3] , and dimeric aaptamine alkaloids, suberitines B and D, showed more potent cytotoxicities than their monomers against the selected P388 cells [36] . Thus, another objective in the present study was to discover the structural motif important for anti-biofilm activities against S. aureus. The results suggested that the double bond between C-1 and C-10 of citrinin derivatives and the C-C connection position of two chromone monomers may significantly affect the anti-biofilm activity against S. aureus (Fig. 1, Table 1 , and Fig. S1 ).
The mechanism governing the formation of S. aureus biofilm is complicated and involves environmental factors, quorum sensing, proteases, DNase, and other global regulators [17] . In the present study, qRT-PCR data showed that SAD regulated in varying degrees the expressions of 17 biofilm-related genes in planktonic S. aureus cells and biofilms (Fig. 5) . In planktonic cells, the transcriptional levels of negative biofilm regulators (agr and isaA) and three PSMs controlled by agr were increased by SAD (Fig. 5A) , which supported its anti-biofilm activity on S. aureus, because induction of agr and/or isaA resulted in the inhibition of S. aureus biofilm formation and three PSMs played a negative role in biofilm formation [37] [38] [39] [40] . On the other hand, aur overexpression inhibited biofilm formation in S. aureus sigB mutants and aur/sspB deletion increased biofilm formation in S. aureus sigB deletions [41, 42] . Meanwhile, when S. aureus was incubated with purified Nuc2, the presence of Nuc2 could prevent biofilm formation in a dose-dependent manner [43] . Thus, the increased transcriptional expression of agr, isaA, PSMs, aur, sspB, and nuc2 in planktonic cells might be one explanation for the inhibition of S. aureus biofilm formation caused by SAD. In formed biofilms, the expression levels of icaA and icaD were down-regulated (Fig. 5B) , which was in accordance with previous studies where repression of ica expression is the best understood mechanism in the inhibition of biofilm formation [44] [45] . Furthermore, sigB disruption led to the inhibition of S. aureus biofilm formation [46] , which suggested that the down-regulated expression of sigB may be another reason for the inhibition of biofilm formation caused by SAD. Thus, these findings demonstrated that SAD inhibits biofilm formation by regulating the transcriptional levels of biofilm-associated genes in different ways under different conditions in S. aureus, which indicated that the biofilm formation of S. aureus is a complicated process. Further genetic studies are required to obtain more details of the molecular mechanisms responsible for the effects of SAD on S. aureus biofilms.
It is urgently needed to find novel strategies to control pathogenic S. aureus. This study demonstrates that many natural products isolated from marine-derived fungi have significant antibacterial and anti-biofilm activities, especially SAD with its strong ability of inhibiting the formation of S. aureus biofilm, and which with the increased antibacterial and anti-biofilm activities of the antibiotics ampicillin sodium salt, vancomycin HCl or chloramphenicol may be regarded as a potential biofilm inhibitor against S. aureus. The findings strongly support that marine fungi are important resources of biofilm inhibitors.
